168 related articles for article (PubMed ID: 33481149)
1. Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
Patrizz A; Dono A; Zhu P; Tandon N; Ballester LY; Esquenazi Y
J Neurooncol; 2021 Mar; 152(1):163-172. PubMed ID: 33481149
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
Ellsworth S; Ye X; Grossman SA
Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
[TBL] [Abstract][Full Text] [Related]
3. Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.
Dono A; Amsbaugh M; Martir M; Smilie RH; Riascos RF; Zhu JJ; Hsu S; Kim DH; Tandon N; Ballester LY; Blanco AI; Esquenazi Y
J Neurooncol; 2021 Mar; 152(1):153-162. PubMed ID: 33492602
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma Recurrence Versus Treatment Effect in a Pathology-Documented Series.
Himes BT; Arnett AL; Merrell KW; Gates MJ; Bhargav AG; Raghunathan A; Brown DA; Burns TC; Parney IF
Can J Neurol Sci; 2020 Jul; 47(4):525-530. PubMed ID: 32077389
[TBL] [Abstract][Full Text] [Related]
5. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
6. Impact of Resecting Radiation Necrosis and Pseudoprogression on Survival of Patients with Glioblastoma.
Grossman R; Shimony N; Hadelsberg U; Soffer D; Sitt R; Strauss N; Corn BW; Ram Z
World Neurosurg; 2016 May; 89():37-41. PubMed ID: 26805684
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract][Full Text] [Related]
8. Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma.
Dono A; Zhu P; Holmes E; Takayasu T; Zhu JJ; Blanco AI; Hsu S; Bhattacharjee MB; Ballester LY; Kim DH; Esquenazi Y; Tandon N
J Neurooncol; 2022 Jan; 156(2):353-363. PubMed ID: 34997451
[TBL] [Abstract][Full Text] [Related]
9. Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
Hu LS; Eschbacher JM; Heiserman JE; Dueck AC; Shapiro WR; Liu S; Karis JP; Smith KA; Coons SW; Nakaji P; Spetzler RF; Feuerstein BG; Debbins J; Baxter LC
Neuro Oncol; 2012 Jul; 14(7):919-30. PubMed ID: 22561797
[TBL] [Abstract][Full Text] [Related]
10. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
12. Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence.
Blasel S; Zagorcic A; Jurcoane A; Bähr O; Wagner M; Harter PN; Hattingen E
J Neuroimaging; 2016; 26(1):116-23. PubMed ID: 25907688
[TBL] [Abstract][Full Text] [Related]
13. The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents.
Kurdi M; Shafique Butt N; Baeesa S; Alghamdi B; Maghrabi Y; Bardeesi A; Saeedi R; Al-Sinani T; Alghanmi N; Bari MO; Samkari A; Lary AI
Pathol Oncol Res; 2021; 27():1609778. PubMed ID: 34257620
[TBL] [Abstract][Full Text] [Related]
14. Recurrence Pattern Analysis of Primary Glioblastoma.
Rapp M; Baernreuther J; Turowski B; Steiger HJ; Sabel M; Kamp MA
World Neurosurg; 2017 Jul; 103():733-740. PubMed ID: 28434963
[TBL] [Abstract][Full Text] [Related]
15. Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.
Ogura K; Mizowaki T; Arakawa Y; Ogura M; Sakanaka K; Miyamoto S; Hiraoka M
Radiat Oncol; 2013 Apr; 8():97. PubMed ID: 24499582
[TBL] [Abstract][Full Text] [Related]
16. Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection.
Ahn S; Park JS; Song JH; Jeun SS; Hong YK
World Neurosurg; 2020 Jan; 133():e640-e645. PubMed ID: 31568907
[TBL] [Abstract][Full Text] [Related]
17. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
[TBL] [Abstract][Full Text] [Related]
18. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
[TBL] [Abstract][Full Text] [Related]
19. Presence of Histopathological Treatment Effects at Resection of Recurrent Glioblastoma: Incidence and Effect on Outcome.
Dalle Ore CL; Chandra A; Rick J; Lau D; Shahin M; Nguyen AT; McDermott M; Berger MS; Aghi MK
Neurosurgery; 2019 Dec; 85(6):793-800. PubMed ID: 30445646
[TBL] [Abstract][Full Text] [Related]
20. Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.
Shields LB; Kadner R; Vitaz TW; Spalding AC
Radiat Oncol; 2013 Apr; 8():101. PubMed ID: 23618500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
